Poop pills aim to break the cycle of recurrent c. diff
NCT ID NCT07458984
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking capsules made from healthy donor stool (fecal microbiota transplantation, or FMT) can prevent another bout of C. diff infection in people who have had it come back at least twice. 76 adults will receive either active FMT capsules or placebo, and researchers will track who gets diarrhea and a positive C. diff test within 12 weeks. The goal is to see if this simple pill approach works better than a dummy treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fecal microbiota (healthy donor stool) in oral capsules
What this could lead to
If it works, this could offer a simple, pill-based way to prevent recurrent C. diff infections without needing antibiotics or hospital procedures.
What could go wrong
This is a phase 3 trial, but it's still relatively small (76 people). The placebo group may also show improvement, and long-term safety or effectiveness beyond 12 weeks isn't yet known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Helsinki University Hospital
RECRUITINGHelsinki, Uusimaa, 00290, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••